台灣生技產黨發展已歷時30 多年，生 技產業發展重點在歷經多次生技產業策略 諮議委員會會議決議後，決定以製藥、圖 療器材、新興生技為主要設置方向口至今 已經取得一定的成績，生技產業市值在 2010 年後有逐漸邁向兆元產業的趨勢。另 一方面，本研究藉由專利兮析探討技術發 展動態，以瞭解生技產業技術之種劣勢及 強弱所在，選擇新竹、中科、南科三大科 學團區生技廠商之美國核准專利做為分析 標的。團區的生技專利核准數量相較其他 產業為低，園民發農階段的萌芽間，在專 利分類的類型也偏重測量測試的槍測類及 有機化學、生物化學等製轟製程開發。從 專利技術功效分析顯示，科學園區生技產業的製麗與醫療器材分別集中在製程改良聞盤及器材結構設計改良。在產品類型上多為學名藥、保健食品及血糖計、溫度計等措測設備。從專制分析結果及產品盤點顯示台灣生技產黨發展仍屬於起步狀態，技術上仍待累積以強化未來產晶競爭力，而未來生技產業發麗應朝向新藥開發及中大型昌瘴槍測儀器，以提升整體生技產黨之技術水準。

The development of Taiwan* s biotechnology industry has been going for more than 30 years so far. After several meetings of Bio Taiwan Commission (BTC)t the main direction of the development of biotechnology industry has been decided to be pharmacy, medical devices and emerging biotechnology, and the development has already achieved certain results. Since 2010, the biotechnology industry has gradually shown its potential for being the next trillion-dollar industry. Moreover, in order to have an understanding of the advantages and disadvantages of the biotechnology industry, it would be important to explore the technological developments based on the patent analysis. Therefore, this article has chosen the patents that have been developed by the biotechnology companies in Taiwan^ science parks and approved by the U.S. patent office as the subject of analysis. Compared to other industries, the number of approved biotechnology patents is low and is still in its developmental stage of growth, In addition, the patents tend to focus on the measurement type such as organic chemistry, biochemistry and other development of pharmaceutical process. According to the patented technology efficacy analysis, the biotechnology companies in science parks tend to focus on the improvement and development of the pharmaceutical process and the improvement of the design of medical equipment, and the types of of the products are mostly the generic drugs, health food, and certain testing equipment such as blood glucose meters and thermometers. The results of the patent analysis and the product sorting out have shown tiiat our biotechnology industry is still at its initial state and needs to improve the technology to enhance the competitiveness in the fu-ture. The future development of our biotechnology industry should be focused on the development of new drugs and medium- to large-scale medical testing equipment to improve the overall technological level of the biotechnology industry.